Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-21

FDA Approved: TAVABOROLE — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Tavaborole as a generic product under an Original Application (ANDA) by Alembic Pharmaceuticals Inc., expanding access to treatment for onychomycos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tavaborole (Tavaborole)

Snippet

ORIG AP for TAVABOROLE (TAVABOROLE)